Posts Tagged ‘thiazolidinediones’

September 5th, 2013

Rosiglitazone Revisited


Richard G. Bach discusses his study group’s observational analysis of data from the BARI 2D trial regarding outcomes associated with rosiglitazone.

July 16th, 2012

Selections from Richard Lehman’s Literature Review: July 16th

This week’s topics include studies on rhythm vs. rate control in AF, thiazolidinediones and the risk for macular edema, and the effect of acadesine on morbidity and mortality associated with CABG.